SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending sharply as investors react to its selection for the U.S. Department of Energy's Genesis Mission, a move seen as significant validation for its AI cloud infrastructure. This development, coupled with an analyst upgrade and renewed optimism in the broader AI sector, is igniting intense community discussions about a potential short squeeze, despite recent volatility.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending strongly following a new "Overweight" rating and a $20 price target from KeyBanc, driving significant bullish sentiment. The community is buzzing with anticipation over an imminent NASA Lunar Terrain Vehicle (LTV) contract award, fueling discussions of a potential short squeeze and long-term upside in the burgeoning space exploration sector. While some express caution regarding current valuations, the dominant conversation centers on LUNR's prospects to lead future lunar missions and its continued growth.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending sharply lower following its earnings report, despite beating revenue and EPS estimates, driven by significant concerns over declining sales in China and substantial gross margin compression. The community is fiercely debating whether this steep sell-off is an overreaction to a strong global brand or a justified repricing reflecting intense competition and ongoing operational challenges.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending due to its announced merger with a nuclear fusion company, a significant pivot from its established social media business. This unexpected strategic shift is fueling intense debate, with supporters highlighting the long-term potential of fusion energy and the company's newfound technological focus. Critics, however, express skepticism about the financial viability and potential for dilution, making it a highly volatile stock actively discussed across the market.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is capturing investor attention due to intense options activity, with a notable surge in calls expiring next week, sparking discussions of a potential gamma squeeze. The community is actively anticipating imminent NOAA permit approval and government funding, which, alongside a rumored strategic partnership with Korea Zinc for critical mineral refining in the US, positions TMC centrally in the push to secure domestic supply chains amidst heightened geopolitical focus on rare earths.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is experiencing significant volatility amid quadruple witching, fueling intense debate among traders. Bulls anticipate a substantial rally, driven by recent analyst upgrades and long-term optimism around AI and robotaxi developments. Conversely, bears express strong skepticism, highlighting FSD limitations, sales concerns, and allegations of market manipulation, particularly around options expiration.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing intense market activity driven by recent announcements, including substantial CEPI funding for a pivotal pandemic flu vaccine study and positive EU regulatory steps for a next-generation COVID vaccine. However, community sentiment is sharply divided; many bulls highlight the promising pipeline and potential for a short squeeze, while skeptics voice concerns over mRNA technology and increasing regulatory scrutiny. This creates a highly polarized conversation surrounding Moderna's valuation and future market direction.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is generating significant buzz due to the highly anticipated BlueBird 6 satellite launch, with community discussions swirling around its precise timing and the broader implications for ubiquitous satellite-to-device connectivity. Bulls are optimistic about potential government contracts and a looming short squeeze, viewing successful deployment as a validation of the company's long-term vision. However, skepticism persists among some, citing past delays and recent institutional selling, as the market closely watches for execution within the trending space sector.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is surging after securing a significant $805 million contract from the Space Development Agency to build 18 missile-tracking satellites, alongside successfully accelerating a U.S. Space Force mission. This landmark award is fueling widespread bullish sentiment, with the community emphasizing the company's strengthening position as a vertically integrated defense-space manufacturer and anticipating further large government contracts within the rapidly expanding space sector.

Starfighters Space Inc

Starfighters Space Inc. is a focal point of discussion following its recent listing, touted as a unique commercial space pure-play operating supersonic aircraft from NASA's Kennedy Space Center. The community is actively debating its potential as a significant player in the growing aerospace sector, with conversations ranging from its 'moonshot' prospects to concerns about high volatility and dilution dynamics. This engagement highlights investor interest in innovative space ventures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Frazier Life Sciences Management L.P. Has $17.79 Million Position in Lexeo Therapeutics, Inc. $LXEO

Frazier Life Sciences Management L.P. lifted its holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) by 363.1% in the 2nd quarter, according to the company in its most recent disclosure...

Lexeo Therapeutics' (LXEO) Buy Rating Reaffirmed at Chardan Capital

Chardan Capital reaffirmed a "buy" rating and issued a $17.00 price objective on shares of Lexeo Therapeutics in a research report on Thursday...

Lexeo Therapeutics (NASDAQ:LXEO) Trading Down 7.8% - What's Next?

Lexeo Therapeutics (NASDAQ:LXEO) Shares Down 7.8% - Here's What Happened...

Lexeo Therapeutics (NASDAQ:LXEO) Now Covered by Analysts at Cantor Fitzgerald

Cantor Fitzgerald initiated coverage on shares of Lexeo Therapeutics in a research note on Monday. They set an "overweight" rating and a $19.00 target price for the company...

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells 1,127 Shares of Stock

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Get Free Report) CEO Richard Nolan Townsend sold 1,127 shares of the company's stock in a transaction that occurred on Tuesday, November 18th. The stock was...

Lexeo Therapeutics (NASDAQ:LXEO) Coverage Initiated at Cantor Fitzgerald

Cantor Fitzgerald started coverage on shares of Lexeo Therapeutics in a research report on Thursday. They set an "overweight" rating and a $19.00 price target for the company...

Equities Analysts Set Expectations for LXEO FY2025 Earnings

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) - Equities researchers at HC Wainwright raised their FY2025 earnings per share estimates for Lexeo Therapeutics in a note issued to investors on...

Wall Street Analysts Predict a 124.3% Upside in Lexeo Therapeutics, Inc. (LXEO): Here's  What You Should Know

The consensus price target hints at a 124.3% upside potential for Lexeo Therapeutics, Inc. (LXEO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Research Analysts Set Expectations for LXEO FY2025 Earnings

Lexeo Therapeutics, Inc. (NASDAQ:LXEO - Free Report) - Equities researchers at Leerink Partnrs increased their FY2025 earnings per share estimates for shares of Lexeo Therapeutics in a report...

Lexeo Therapeutics (NASDAQ:LXEO) Announces Earnings Results

Lexeo Therapeutics (NASDAQ:LXEO - Get Free Report) released its earnings results on Wednesday. The company reported ($0.33) EPS for the quarter, topping analysts' consensus estimates of ($0.48) by...

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

LXEO
Lexeo Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LXEO News

LXEOLexeo Therapeutics Inc.